Harnessing stereotactic precision in the fight against primary kidney cancer: time for a randomised trial?
Lancet Oncol
.
2024 Mar;25(3):267-269.
doi: 10.1016/S1470-2045(24)00083-4.
Authors
Daniel X Yang
1
,
Raquibul Hannan
2
Affiliations
1
Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX 75390-9303, USA.
2
Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX 75390-9303, USA. Electronic address: raquibul.hannan@utsouthwestern.edu.
PMID:
38423040
DOI:
10.1016/S1470-2045(24)00083-4
No abstract available
MeSH terms
Humans
Kidney Neoplasms* / surgery